Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Orthosera GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11270
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Orthosera GmbH (OrthoSera), formerly Lacerta Technologies GmbH is a regenerative medicine company that develops blood serum for human diseases. The company offers Albumin, a bone protein used in treatment of patients suffering from bone loss. It develops technologies for identification of new disease areas and to advance development of pipeline products in orthopedic, dental and spine applications. OrthoSera also offers BoneAlbumin and hyper acute serum. The company’s BoneAlbumin is a bone void filler used in dentistry and orthopaedics. It conducts research on bone grafting, wound healing, osteoarthritis, and dental and orthopedic indications. OrthoSera is headquartered in Krems an der Donau, Austria.

Orthosera GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orthosera GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orthosera GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orthosera GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
OrthoSera Raises Funds through Series B Financing 11
OrthoSera Raises Funds in Financing Round 12
Lacerta Technologies Raises Funds Through Seed Financing 13
Orthosera GmbH – Key Competitors 14
Orthosera GmbH – Key Employees 15
Orthosera GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Orthosera GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orthosera GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orthosera GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Orthosera GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OrthoSera Raises Funds through Series B Financing 11
OrthoSera Raises Funds in Financing Round 12
Lacerta Technologies Raises Funds Through Seed Financing 13
Orthosera GmbH, Key Competitors 14
Orthosera GmbH, Key Employees 15

List of Figures
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orthosera GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acorn Energy Inc (ACFN):石油・ガス:M&Aディール及び事業提携情報
    Summary Acorn Energy Inc (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and comme …
  • ATCC:製薬・医療:M&Aディール及び事業提携情報
    Summary ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other ma …
  • SeaSpine Holdings Corporation (SPNE):企業の財務・戦略的SWOT分析
    SeaSpine Holdings Corporation (SPNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Thundelarra Ltd (THX):企業の財務・戦略的SWOT分析
    Summary Thundelarra Ltd (Thundelarra) is a mining and mineral exploration company. The company acquires, explores and develops lead, zinc, silver, nickel, graphite, copper, gold and uranium prospects in Western Australia and the Northern Territory. Its projects include Red Bore Copper-Gold Project, …
  • IndusInd Bank Ltd:企業のM&A・事業提携・投資動向
    IndusInd Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IndusInd Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Serco Inc:企業の戦略的SWOT分析
    Serco Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • SynergEyes Inc:医療機器:M&Aディール及び事業提携情報
    Summary SynergEyes Inc (SynergEyes) is a medical device company that provides contact lenses. The company provides hybrid contact lenses to transform vision for patients with astigmatism, presbyopia, presbyopia, myopia, hyperopia, keratoconus, and other eye conditions. It offers ultrahealth hybrid l …
  • Ecsponent Limited (ECS):企業の財務・戦略的SWOT分析
    Ecsponent Limited (ECS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • China Haisheng Juice Holdings Co Ltd:戦略・SWOT・企業財務分析
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Carmell Therapeutics Corp:製品パイプライン分析
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio encompasses adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for tot …
  • Trustwave Holdings Inc:企業の戦略的SWOT分析
    Trustwave Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Oceaneering International Inc (OII):石油・ガス:M&Aディール及び事業提携情報
    Summary Oceaneering International Inc (Oceaneering) is an oilfield provider of engineered products and services. The company serves primarily the offshore oil and gas industry, with a focus on deepwater applications. Its oilfield products and services include remotely operated vehicles, specialty su …
  • SoftBank Group Corp (9984):企業の財務・戦略的SWOT分析
    SoftBank Group Corp (9984) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sammons Enterprises Inc:戦略・SWOT・企業財務分析
    Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kainos Medicine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kainos Medicine Inc (Kainos) is a drug discovery and development company that develops drugs and medicines for cancer, brain disease, metabolic and infectious diseases. The company offers antiviral drugs, Parkinson’s drugs, HIV drugs, anticancer drugs and HBV medications. Its anticancer drug …
  • IDT Biologika GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary IDT Biologika GmbH (IDT Biologika), a subsidiary of Klocke Pharma-Service GmbH, is a vaccines and pharmaceuticals manufacturer. The company offers contract manufacturing services. It provides integrated development and manufacturing services in four major areas of animal health, vaccines, ph …
  • Wheaton Precious Metals Corp:企業の戦略・SWOT・財務情報
    Wheaton Precious Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Wheaton Precious Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Transocean Ltd (RIG):石油・ガス:M&Aディール及び事業提携情報
    Summary Transocean Ltd (Transocean) is a provider of offshore contract drilling services to the oil and gas industry. The company specializes in the technically demanding regions of the global offshore drilling business with a particular focus on deepwater and harsh environment drilling services. Tr …
  • Absorption Systems LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Absorption Systems LLC (Absorption Systems), formerly Absorption Systems LP is a pre-clinical contract research organization that develops and implements research tools. The organization offers preclinical testing of biologics, drugs, and medical devices. It also develops and implements rese …
  • Zelan Bhd:企業の戦略・SWOT・財務情報
    Zelan Bhd - Strategy, SWOT and Corporate Finance Report Summary Zelan Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆